UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Nature communications, ISSN 2041-1723, 03/2016, Volume 7, Issue 1, pp. 11128 - 11128
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Kidney - pathology | Drug Resistance, Multiple - drug effects | Humans | Colony Count, Microbial | Candidiasis - microbiology | Antifungal Agents - therapeutic use | Candidiasis - drug therapy | Gene Deletion | Genes, Fungal | Echinocandins - pharmacology | Disease Models, Animal | Antifungal Agents - pharmacology | Drug Resistance, Multiple - genetics | Kidney - drug effects | Drug Resistance, Fungal - drug effects | Genotype | Drug Resistance, Fungal - genetics | Mutation - genetics | Kidney - microbiology | Phenotype | Animals | Candida glabrata - isolation & purification | Echinocandins - therapeutic use | Mice | Candida glabrata - genetics | Index Medicus
Journal Article
FEMS microbiology reviews, ISSN 0168-6445, 03/2012, Volume 36, Issue 2, pp. 288 - 305
epidemiology | candidosis | Candida species | virulence factors | antifungal resistance | Antifungal resistance | Candidosis | Virulence factors | Epidemiology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Fundamental and applied biological sciences. Psychology | Biological and medical sciences | Miscellaneous | Mycology | Antifungal Agents - pharmacology | Candida - genetics | Candida - metabolism | Candida glabrata - pathogenicity | Humans | Candida tropicalis - pathogenicity | Candidiasis - epidemiology | Candida tropicalis - drug effects | Candidiasis - microbiology | Candida glabrata - metabolism | Antifungal Agents - therapeutic use | Animals | Candida tropicalis - genetics | Candida - pathogenicity | Candidiasis - drug therapy | Candida tropicalis - metabolism | Candida - drug effects | Candida glabrata - genetics | Drug Resistance, Fungal | Candida glabrata - drug effects | Medical equipment | Epidemics | Pathogens | Medical devices | Fungicides | Identification methods | Virulence | Biology | Pathogenicity | Fungi | Biofilms | Medical electronics | Immunocompromised hosts | Species | Index Medicus
Journal Article
Emerging infectious diseases, ISSN 1080-6040, 11/2014, Volume 20, Issue 11, pp. 1833 - 1840
Infectious Diseases | Immunology | Life Sciences & Biomedicine | Science & Technology | Antifungal Agents - pharmacology | Drug Resistance, Multiple, Fungal | Humans | Middle Aged | Risk Factors | Candidiasis - mortality | Male | Candidiasis - microbiology | Cause of Death | Microbial Sensitivity Tests | Young Adult | Neoplasms - complications | Candidiasis - etiology | Candida glabrata - isolation & purification | Adolescent | Aged, 80 and over | Adult | Female | Aged | Child | Drug Resistance, Fungal | Candida glabrata - drug effects | Cancer patients | Medical examination | Amphotericin B | Fluconazole | Antiparasitic agents | Drug resistance | Drug therapy | Health aspects | Blood | Index Medicus | Infection in Cancer Patients | fungi | Drug-Resistant | Candida glabrata | cancer | Research | candidemia | antifungal resistance
Journal Article
European journal of clinical microbiology & infectious diseases, ISSN 0934-9723, 5/2014, Volume 33, Issue 5, pp. 673 - 688
Medical Microbiology | Internal Medicine | Biomedicine | Infectious Diseases | Life Sciences & Biomedicine | Microbiology | Science & Technology | Biological and medical sciences | Infectious diseases | Medical sciences | Antifungal Agents - pharmacology | Candida glabrata - physiology | Humans | Candidiasis - epidemiology | Candidiasis - microbiology | Candidiasis - pathology | Drug Resistance, Fungal | Candida glabrata - drug effects | Immunotherapy | Index Medicus
Journal Article
Clinical infectious diseases, ISSN 1058-4838, 6/2013, Volume 56, Issue 12, pp. 1724 - 1732
Antifungals | Azoles | Health outcomes | Microbial sensitivity tests | Mortality | Polyenes | Infections | Candida glabrata | ARTICLES AND COMMENTARIES | Genetic mutation | Blood | susceptibility | micafungin | resistance | echinocandin | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Biological and medical sciences | Infectious diseases | Medical sciences | Humans | Middle Aged | Child, Preschool | Infant | Male | Candidiasis - microbiology | Antifungal Agents - therapeutic use | Microbial Sensitivity Tests | Candidiasis - drug therapy | Aged, 80 and over | Adult | Female | Retrospective Studies | Child | Drug Resistance, Fungal | Echinocandins - pharmacology | Infant, Newborn | Glucosyltransferases - genetics | Antifungal Agents - pharmacology | Membrane Proteins - genetics | Treatment Outcome | Fungal Proteins - genetics | Mutation - genetics | Adolescent | Echinocandins - therapeutic use | Aged | Candida glabrata - genetics | Candida glabrata - drug effects | Complications and side effects | Drug resistance in microorganisms | Candidiasis | Gene mutations | Echinocandins | Dosage and administration | Genetic aspects | Research | Drug therapy | Risk factors | Fungal infections | Mutation | Drug resistance | Genes | Pesticides | Index Medicus | and Commentaries
Journal Article
Cancer, ISSN 0008-543X, 06/2008, Volume 112, Issue 11, pp. 2493 - 2499
Cancer patient | Hematologic malignancies | Candidemia | Solid tumors | Epidemiology | Life Sciences & Biomedicine | Oncology | Science & Technology | Human mycoses | Infectious diseases | Mycoses | Biological and medical sciences | Multiple tumors. Solid tumors. Tumors in childhood (general aspects) | Medical sciences | Mycotic sepsis | Tumors | Hematologic Neoplasms - microbiology | Humans | Middle Aged | Risk Factors | Candidiasis - epidemiology | Male | Hematologic Neoplasms - epidemiology | Candidiasis - microbiology | Fungemia - microbiology | Fluconazole - therapeutic use | Antifungal Agents - therapeutic use | Neutropenia - etiology | Candida - classification | Candida - pathogenicity | Candidiasis - drug therapy | Fungemia - drug therapy | Hematologic Neoplasms - drug therapy | Female | Retrospective Studies | Fungemia - epidemiology | Amphotericin B - therapeutic use | Drug Resistance, Fungal | Catheterization, Central Venous - adverse effects | Cohort Studies | Complications and side effects | Candidiasis | Causes of | Research | Blood diseases | Risk factors | Index Medicus | Abridged Index Medicus
Journal Article
Mycoses, ISSN 0933-7407, 08/2015, Volume 58, Issue 8, pp. 445 - 450
azole resistance | fluconazole | echinocandin resistance | Candidaemia | echinocandin | Candida glabrata | azole antifungal | Echinocandin | Echinocandin resistance | Fluconazole | Azole resistance | Azole antifungal | Life Sciences & Biomedicine | Dermatology | Mycology | Science & Technology | Candida glabrata - pathogenicity | Candida glabrata - physiology | Candidiasis, Invasive - epidemiology | Humans | Azoles - therapeutic use | Antifungal Agents - therapeutic use | Microbial Sensitivity Tests | Candidiasis, Invasive - diagnosis | Candidiasis, Invasive - drug therapy | Echinocandins - therapeutic use | Mutation | Candida glabrata - genetics | Candidiasis, Invasive - microbiology | Drug Resistance, Fungal | Candida glabrata - drug effects | Index Medicus
Journal Article